Complete Serologic Response to Pembrolizumab in a Woman With Chemoresistant Metastatic Choriocarcinoma

J Clin Oncol. 2017 Sep 20;35(27):3172-3174. doi: 10.1200/JCO.2017.74.4052. Epub 2017 Jul 25.

Authors

Marilyn Huang¹, Andre Pinto¹, Rosa Patricia Castillo¹, Brian M Slomovitz¹

Affiliation

¹ Marilyn Huang, Andre Pinto, Rosa Patricia Castillo, and Brian M. Slomovitz, University of Miami, Miami, FL.

PMID: 28742453
DOI: 10.1200/JCO.2017.74.4052

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Antineoplastic Agents, Immunological / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
B7-H1 Antigen / antagonists & inhibitors
B7-H1 Antigen / immunology
Choriocarcinoma / blood
Choriocarcinoma / drug therapy*
Choriocarcinoma / immunology
Choriocarcinoma / secondary
Chorionic Gonadotropin, beta Subunit, Human / blood*
Drug Resistance, Neoplasm*
Female
Humans
Pregnancy
Treatment Outcome
Uterine Neoplasms / blood
Uterine Neoplasms / drug therapy*
Uterine Neoplasms / immunology
Uterine Neoplasms / pathology

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
B7-H1 Antigen
CD274 protein, human
Chorionic Gonadotropin, beta Subunit, Human
pembrolizumab